Home » Topics » BioWorld Science

BioWorld Science
RSS

How mothers drive their offspring to drink

July 15, 2019

CD73 target defined for subgroup of AML precision medicine

July 15, 2019

Roche presents interim results from part 1 of FIREFISH study of risdiplam

July 15, 2019

Results presented from phase III EAT2TREAT study of fampridine and acetazolamide

July 15, 2019

Recruitment ongoing in phase I study of BI-836880 for the treatment of wAMD

July 15, 2019

EIP Pharma initiates phase II study of neflamapimod in cognitive dysfunction associated with DLB

July 15, 2019

Allist Pharmaceuticals initiates phase III FLAG study of alflutinib mesylate in NSCLC

July 15, 2019

Slt-deficient F. novicida mutant shows attenuation and protects against pneumonic challenge in mice

July 15, 2019

Human biodistribution and dosimetry of the PET imaging agent [11C]trimethoprim

July 12, 2019

Beta Pharma enrolling patients with NSCLC for phase III trial of BPI-7711

July 12, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...